Abstract |
Complete deficiency of the complement C4A isotype is a known genetic risk factor for systemic lupus erythematosus (SLE). The disease phenotype of C4A-deficient patients has never been defined. Among 200 patients with SLE from five centers, 18 (9%) with C4A deficiency were identified. These individuals were compared to those who were C4A replete with regard to a series of clinical and serologic features. The only significant differences between the two groups were in the presence of renal disease (C4A deficient, 11%; C4A replete, 46%; P < 0.006) and a decrease in the serum concentrations of C3 (C4A deficient, 11%; C4A replete, 35%; P < 0.04). There was also a trend for the C4A-deficient individuals to have milder disease. In light of the tendency for C4A-deficient individuals to have lower serum concentrations of C4, it is important that such patients not be subjected to overly aggressive efforts to "normalize" their C4 levels.
|
Authors | T R Welch, C Brickman, N Bishof, S Maringhini, M Rutkowski, M Frenzke, N Kantor |
Journal | Journal of clinical immunology
(J Clin Immunol)
Vol. 18
Issue 1
Pg. 48-51
(Jan 1998)
ISSN: 0271-9142 [Print] Netherlands |
PMID | 9475353
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Complement C3
- Complement C4a
|
Topics |
- Adult
- Alleles
- Black People
(genetics)
- Complement C3
(analysis)
- Complement C4a
(analysis, deficiency)
- Female
- Humans
- Lupus Erythematosus, Systemic
(blood, genetics)
- Male
- Middle Aged
- Multicenter Studies as Topic
- Phenotype
- Severity of Illness Index
- White People
(genetics)
|